Oracle's stock price drops 8.76% to $119.22, with bearish signals dominating the daily chart
The Cryptonomist
1h ago
Ai Focus
Oracle's stock price closed at $119.22 on Monday, down from the previous close of $130.67. The daily chart structure is bearish, with the closing price below all three moving averages and close to the lower band of the Bollinger Bands. Although a positive MACD bar chart appears on the 15-minute chart, the hourly chart remains oversold but still in a bearish state.
Helpful
No.Help

The daily chart structure of Oracle's stock is bearish, with the closing price approaching the lower band of the Bollinger Bands and below the three-day moving averages. The hourly chart readings are in an oversold zone, which complicates the situation further. However, the positive MACD bar on the 15-minute chart is merely a signal at a single point in time and does not constitute a confirmation of a bullish trend at the daily chart level.

On Monday, November 2, 2026, Oracle opened at $125.88, hit a low of $118.43 during the session, and a high of $126.50, closing at $119.22. The previous closing price was $130.67. A total of 58,484,300 shares were traded on that trading day.

Key Points

  • The daily line RSI14 is at 38.34, the daily line MACD bar chart shows -0.09, and the MACD line is at -3.26, which is below the signal line of -3.17.
  • The closing price was only slightly higher than the lower band of the daily Bollinger Bands at $119.19, and it was also below the 20-day EMA at $133.24, the 50-day EMA at $138.74, and the 200-day EMA at $159.50.
  • The hourly line RSI14 is at 26.03, which is in an oversold range; the hourly line MACD is at -3.62, which is below the signal line of -2.05.
  • The 15-minute MACD bar chart shows a value of 0.11, while the MACD line shows -2.13, which is higher than the signal line of -2.24; however, the price is still below the middle band of the 15-minute Bollinger Bands at 121.26 USD.

Oracle's stock faces a bearish daily chart structure

The daily moving averages are arranged in a bearish trend. The price is below the 20-day EMA of $133.24, followed by the 50-day EMA of $138.74 and the 200-day EMA of $159.50. This arrangement supports a bearish outlook, as all three moving averages are above the closing price.

Meanwhile, the daily RSI14 indicator is at 38.34, which is below the neutral level of 50, but it has not yet entered an oversold zone. The daily MACD bar chart has dropped from 0.86 on the previous trading day to -0.09, and the MACD line is at -3.26, which is lower than the signal line of -3.17, confirming a bearish momentum in the daily chart.

The closing price is not far above the lower band of the daily Bollinger Bands at $119.19. The middle band is at $133.57, and the upper band is at $147.95, indicating that the price is closer to the lower edge of the range rather than the middle position. The daily ATR14 has risen to $7.96, higher than the previous $7.64, suggesting that the average range of fluctuations is larger than the previous reading.

Weak hourly charts coexist with mixed execution signals.

Similarly, the hourly chart also confirms a bearish trend on the daily chart. The closing price is below the 20-period EMA at $127.34, the 50-period EMA at $129.92, and the 200-period EMA at $135.89; all of these moving averages are also in a bearish alignment.

However, the hourly chart RSI14 shows a value of 26.03, which is in an oversold area. The hourly chart MACD still shows a negative value of -3.62, which is lower than the signal line of -2.05; its bar chart indicates -1.57. Therefore, both oversold readings of RSI and slightly bullish readings of MACD exist simultaneously, rather than forming a bullish reversal.

In contrast, on the 15-minute chart, the MACD line at -2.13 is higher than the signal line at -2.24, forming a positive bar of 0.11. The 15-minute RSI14 is still in an oversold zone, at 28.07. The price is still below the 15-minute Bollinger Bands middle band of $121.26 and the 20-period EMA of $121.45; therefore, the evidence for a bullish outlook is limited to timing signals at the execution level only.

Post-market news pertains to the situation after the market closes.

Long and short conditions for the next trading session

When trading resumes, the daily pivot point is at $121.38, with the first resistance level at $124.34 and the first support level at $116.27. In terms of execution timing, the 15-minute pivot point is at $119, with the first resistance level at $119.56 and the first support level at $118.55. The closing price on Monday was above the 15-minute pivot point but below its first resistance level.

In a bullish scenario, if the price breaks through the first resistance level of $119.56 within 15 minutes, that will provide initial support. Reaching the daily pivot point of $121.38 will offer even stronger support, and if it then breaks through the first daily resistance level of $124.34, that will further strengthen the bullish trend. Nevertheless, the 20-day moving average of $133.24 will still pose a challenge above.

On the contrary, if it falls below the first support level of $118.55 over a 15-minute period as well as the intraday low of $118.43, that would weaken the bullish scenario. At that point, the first support level on the daily chart, which is $116.27, would become the next reference for downward movement. These are all conditional thresholds, not predictions.

Overall, Oracle's stock price is near the lower band of the daily Bollinger Bands, below the daily pivot point for the next trading session, and also below the bearish arranged daily moving averages. The daily ATR14 level is at $7.96, which defines the range of fluctuations. What remains to be seen is whether the positive MACD signal on the 15-minute chart can be supported by the hourly and daily charts.

Frequently Asked Questions

What is the technical analysis of Oracle's stock on a daily basis?

Oracle's stock shows a bearish daily chart structure. The closing price of $119.22 is lower than the three moving averages of the daily charts: the 20-day EMA at $133.24, the 50-day EMA at $138.74, and the 200-day EMA at $159.50. The daily RSI14 is at 38.34, and the daily MACD line is below the signal line.

Are there any positive signs for Oracle's stock?

The 15-minute MACD bar chart shows a value of 0.11, and the MACD line shows -2.13, which is higher than the signal line of -2.24. However, the price is still below the middle band of the 15-minute Bollinger Bands at 121.26 USD. On the hourly chart, the RSI14 indicator shows 26.03, indicating an oversold area, while the MACD indicator on the hourly chart remains bearish.

What key levels need to be watched for in the next trading session?

The daily pivot point is at $121.38, with the first resistance level at $124.34 and the first support level at $116.27. On the 15-minute chart, the pivot point is at $119, with the first resistance level at $119.56 and the first support level at $118.55. The lower band of the daily Bollinger Bands is at $119.19.

Disclaimer

This article is for informational purposes only and does not constitute financial advice, investment advice, or an offer or invitation to buy or sell any financial instruments. The analysis provided does not represent future results. Investing in the financial market carries a high risk of capital loss. Before making any decisions, please be sure to conduct your own research ( DYOR ) and consult a qualified financial advisor.

Cryptonomist and the author do not hold any positions in the financial instruments mentioned in this text, nor have they received any compensation from the companies reported.

This article was generated with the assistance of artificial intelligence and has been reviewed by an editorial team.

Lorenzo Marcek

Lorenzo Marcek is a financial journalist and senior crypto market analyst, renowned for his clear, data-driven reporting on digital assets. With a background in economics and over a decade of experience covering global markets, he focuses on on-chain indicators, institutional adoption trends, and crypto market fluctuations driven by macroeconomic factors. His work combines investigative journalism with technical market insights, making him a trusted source for traders seeking solid, actionable analysis.

Tip
$0
Like
0
Save
0
Views 23
WalletJYS reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Gurman: Apple's first foldable phone iPhone Duo was originally planned to be released in November, but was hastily brought forward to October, resulting in a severe shortage of inventory.
According to Bloomberg reporter Mark Gurman, Apple's first foldable phone, iPhone Duo, was originally scheduled to be released in November this year in the United States and China, but the release date was advanced to October 23 for global sales, resulting in a severe shortage of inventory in the initial stages of market availability. Gurman also mentioned that the hasty adjustment of the release plan may be related to recent issues with the screen hardware that have been exposed.
The Block
·2026-11-03 20:14:31
2
XRP Network Activity Surges, But Why Is the Price Still Under Pressure?
XRP 7,934 new wallets added, with payment volume reportedly rising to 1.33 billion XRP. This indicates increased network activity; however, while the price remains hovering around $1.25, the institutional progress of Ripple and the ecological expansion of XRPL have not yet directly translated into clear buying interest in XRP.
Coinpedia
·2026-11-03 20:14:27
1
Versant Outperforms Expectations, Digital Platform Business Drives Growth
Versant Media announced quarterly results on Tuesday, with both earnings and adjusted EBITDA exceeding expectations, and reaffirmed the full-year guidance for 2026. The company stated that digital platform revenue grew by nearly 10%, and Fandango ticketing revenue reached a new high since the pandemic, although advertising revenue and linear television revenue are still under pressure.
CNBC
·2026-11-03 20:14:25
1
Protalix BioTherapeutics to Release Q3 2026 Financial Reports and Update on Business Progress on November 10
Protalix BioTherapeutics ( NYSE American : PLX ) indicates that the financial results for the third quarter ending September 30 will be announced on November 10, 2026, along with an update on business progress. Management will hold a teleconference and webcast at 8:00 a.m. Eastern Time to discuss the financial report and recent company and regulatory developments.
PR Newswire
·2026-11-03 20:06:15
9
Apple's gross margin outlook puts pressure on tech stocks; reports say U.S. military strikes have driven up oil prices
Apple reports strong earnings, but gross margin guidance falls short of expectations, dragging down tech stocks; meanwhile, reports say U.S. strikes on Iran's Geshem Island drive up crude oil prices.
CNBC
·2026-11-03 20:06:10
14
View More